Rockwell Medical (RMTI) Receivables - Net (2010 - 2026)

Rockwell Medical (RMTI) has reported Receivables - Net for 17 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Net rose 2.73% year-over-year to $8.3 million; the trailing twelve-month figure through Jun 2026 stood at $8.3 million (up 2.73% YoY), and the FY2025 full-year result was $8.1 million, down 1.79% from the prior year.
• Receivables - Net eased to $8.3 million in Q2 2026 per RMTI's latest filing, from $8.8 million in the prior quarter.
• Across five years, Receivables - Net topped out at $11.1 million in Q1 2024 and bottomed at $5.4 million in Q2 2023.
• Historically, Receivables - Net has averaged $8.4 million across 5 years, with a median of $8.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Receivables - Net slumped 33.11% in 2023, then soared 100.33% in 2024.
• Over 5 years, Receivables - Net stood at $6.3 million in 2022, then soared by 74.17% to $10.9 million in 2023, then retreated by 23.94% to $8.3 million in 2024, then dropped by 1.79% to $8.1 million in 2025, then climbed by 1.99% to $8.3 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $8.3 million, $8.8 million, and $8.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.